Cart
sales@molnova.com
BTK inhibitor 1
CAS No. 2230724-66-8
BTK inhibitor 1( —— )
Catalog No. M34749 CAS No. 2230724-66-8
BTK inhibitor 1 (Compound 27) is a BTK inhibitor (IC50: 0.11 nM) with an inhibitory effect on B-cell activation in hWB with an IC50 of 2 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 259 | In Stock |
|
| 2MG | 136 | In Stock |
|
| 5MG | 226 | In Stock |
|
| 10MG | 340 | In Stock |
|
| 25MG | 560 | In Stock |
|
| 50MG | 783 | In Stock |
|
| 100MG | 1051 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBTK inhibitor 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionBTK inhibitor 1 (Compound 27) is a BTK inhibitor (IC50: 0.11 nM) with an inhibitory effect on B-cell activation in hWB with an IC50 of 2 nM.
-
DescriptionBTK inhibitor 8 (Compound 27) is a Btk inhibitor with an IC50 of 0.11 nM. BTK inhibitor 8 inhibits B cell activation in hWB with an IC50 of 2 nM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayTyrosine Kinase
-
TargetBTK
-
RecptorBTK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2230724-66-8
-
Formula Weight474.49
-
Molecular FormulaC24H23FN8O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESFC=1C=C(C2=C3C(NC(=C3)C=4C=NN(C)C4)=NC=N2)C=CC1CNC(=O)C=5N=C(C(C)(C)C)ON5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Musumeci F, et al. Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors. Expert Opin Ther Pat. 2017 Dec;27(12):1305-1318.?
molnova catalog
related products
-
Tilfrinib
Tilfrinib is an effective and selective inhibitor of breast tumor kinase (IC50: 3.15 nM), which displays anti-proliferative activity.
-
BGB-8035
BGB-8035 is an orally available, selective and potent BTK inhibitor with antitumor activity that inhibits BTK, TEC and EGFR.BGB-8035 is used in the study of tumors and autoimmune diseases.
-
BLK degrader 1
BLK degrader 1 is a selective B lymphoid tyrosine kinase (BLK) degrader with anticancer activity and can be used for cancer research.
